KUREvsFXIETF Comparison
ETF 1
KURE
KraneShares MSCI All China Health Care Index ETF
This fund is part of
China Blended Cap
+0.15%
VS
KraneShares MSCI All China Health Care Index ETF (KURE) and iShares China Large-Cap ETF (FXI) belong to the same industry segment: China Blended Cap. KURE's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Energy Materials. In contrast, FXI's top sector exposures are Finance, Technology and Consumer Non-Cyclicals. KURE is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.73% for FXI. KURE is up 0.17% year-to-date (YTD) with +$22M in YTD flows. FXI performs worse with -4.6% YTD performance, and -$1.64B in YTD flows. Run a side-by-side ETF comparison of KURE and FXI below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
KURE vs FXI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/30/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | KURE FXI | +9.84%+14.75% | -0.46%-0.15% | +0.17%-4.60% | -10.50%-0.85% | -4.22%+29.35% | -47.23%-0.00% |
| Flows | KURE FXI | +$21M-$793M | +$17M-$1.58B | +$22M-$1.64B | -$896K-$1.74B | +$22M-$1.64B | -$25M+$790M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | KURE FXI | +31.73%+21.71% | +27.53%+19.80% | +26.47%+25.64% | +27.48%+29.51% |
| Max drawdown | KURE FXI | -16.96%-17.12% | -29.89%-23.30% | -31.17%-28.82% | -62.91%-49.98% |
| Max drawdown duration | KURE FXI | 68d79d | 325d302d | 619d420d | 1815d1365d |
Trading data
KURE | FXI | |
Last sale 7/31/2026 at 1:30 PM | $17.28 | $36.50 |
| Previous close 07/31/2026 | $17.27 | $36.52 |
| Consolidated volume 07/31/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of July 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
KURE | FXI | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 7/31/2026 at 1:30 PM
Live
Closed
KURE | FXI | |
|---|---|---|
| Last price | $17.28 | $36.50 |
| 1D performance | +0.06% | -0.05% |
| AuM | $98.82 M | $4.34 B |
| E/R | 0.79% | 0.73% |
Characteristics
KURE | FXI | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | KraneShares | iShares |
| Benchmark | MSCI China All Shares Health Care 10/40 Index | FTSE China 50 Index |
| N° of holdings | 43 | 51 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 31, 2018 | October 5, 2004 |
| ESG | No | No |
Advertisement
Exposure
Countries
KURE
China
86.22%
Switzerland
8.84%
Other
4.94%
FXI
China
94.31%
Other
5.69%
Sectors
KURE
Healthcare
98.15%
Other
1.85%
FXI
Finance
36.56%
Technology
22.13%
Consumer Non-Cycl.
9.81%
Consumer Cyclical.
8.77%
Other
22.73%
Advertisement
Diversification
KURE
Total weight of top 15 holdings out of 15
65.95%
FXI
Total weight of top 15 holdings out of 15
68.83%
Top 15 holdings
Data as of June 30, 2026
KURE
BeOne Medicines Ltd.
8.84%
Innovent Biologics, Inc.
8.80%
WuXi Biologics (Cayman), Inc.
7.51%
WuXi AppTec Co., Ltd.
5.79%
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
4.59%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
4.27%
Akeso, Inc.
3.72%
CSPC Pharmaceutical Group Ltd.
3.68%
Sino Biopharmaceutical Ltd.
3.39%
WuXi AppTec Co., Ltd.
3.35%
Hansoh Pharmaceutical Group Co., Ltd.
2.85%
3SBio, Inc.
2.49%
Yunnan Baiyao Group Co., Ltd.
2.30%
Shanghai United Imaging Healthcare Co., Ltd.
2.27%
Aier Eye Hospital Group Co., Ltd.
2.10%
FXI
Tencent Holdings Ltd.
9.22%
China Construction Bank Corp.
8.94%
Alibaba Group Holding Ltd.
8.38%
Industrial & Commercial Bank of China Ltd.
6.07%
Xiaomi Corp.
4.41%
Meituan
4.37%
NetEase, Inc.
4.30%
Bank of China Ltd.
3.95%
Ping An Insurance (Group) Co. of China Ltd.
3.87%
BYD Co., Ltd.
3.13%
JD.com, Inc.
2.86%
Baidu, Inc.
2.74%
China Life Insurance Co. Ltd.
2.33%
Trip.com Group Ltd.
2.20%
PetroChina Co., Ltd.
2.07%
Frequently asked questions about KURE and FXI
How have the KURE and FXI ETFs performed in 2026?
As of July 30, 2026, KURE is up 0.17% year-to-date (YTD), while FXI has lost -4.6%. That puts KURE better performer ahead so far this year.
Which ETF is attracting more investor money: KURE or FXI?
Year-to-date, the KURE ETF saw +$22M in flows, compared to -$1.64B for FXI.
Which ETF is more volatile: KURE or FXI?
Over the past year, KURE had a volatility of 27.53%, while FXI experienced 19.8%.
Which ETF is bigger: KURE or FXI?
As of July 30, 2026, KURE holds $98.82 M in assets under management (AUM), while FXI manages $4.34 B.
What sectors do the KURE and FXI ETFs invest in?
KURE leans toward sectors like Healthcare. Meanwhile, FXI focuses on Finance, Technology and Consumer Non-Cyclicals.
What are the top holdings of the KURE ETF and FXI ETF?
KURE top holdings include BeOne Medicines Ltd., Innovent Biologics, Inc. and WuXi Biologics (Cayman), Inc.. FXI holds in its top three: Tencent Holdings Ltd., China Construction Bank Corp. and Alibaba Group Holding Ltd..
Which ETF is more diversified: KURE or FXI?
KURE holds 45 securities with 65.95% of its assets in the top 15. FXI has 51 securities and a top 15 weight of 68.83%.
Advertisement
Latest news about KURE & FXI
Rising Dragon: Top ETFs to Capitalize on China's Surging Stock Market
October 4, 2024
FXI
Growth Potential of China ETFs
January 30, 2023
FXI
Advertisement
Advertisement
